Aurélien Valet

As Chief Executive Officer and member of executive board, Aurélien brings fifteen years of cross-functional leadership experience in Orthobiologics industry.

Prior to joining Graftys in Nov 2021, he served as CEO & President of Biologics 4 life, leading the company’s acquisition and integration by Graftys.

Before his time at bio4life, he served as CEO of Graftys where he was responsible for overseeing the development and commercialization of their innovative injectable bone grafts, successfully achieving several regulatory approvals (510k, CE, ANVISA…) and driving the companys’ peak revenue growth until Graftys’ acquisition end of 2017.

He holds a, executive MBA from Kedge Business School.